Investor Home

Corporate Profile

Apricus is committed to developing novel therapies in areas of high unmet needs. We have disciplined leadership focused on execution and are driving near-term shareholder value through regulatory approval, commercialization and partnering initiatives.

Recent Newsmore >
DateTitle
01/15/19Apricus Biosciences Stockholders Approve Proposed Merger with Seelos Therapeutics, Inc.
Merger Expected to Close in January 2019 SAN DIEGO, Jan. 15, 2019 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq: APRI) has today reported that it obtained stockholder approval as required pursuant to the terms of the merger agreement with Seelos Therapeutics, Inc. and the related securities purchase agreement with selected investors or necessary under Nevada law, in order to complete the merger, the financing and related matters.  The Company announced that over 95% of the votes cast ... 
12/14/18Apricus Biosciences Adjourns Special Meeting of Stockholders to New Date
The Meeting Seeking Stockholder Approval for Proposed Merger with Seelos Therapeutics, Inc. Will Be Reconvened on January 4, 2019 SAN DIEGO, Dec. 14, 2018 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq: APRI) has today convened and adjourned its special meeting of stockholders in order to obtain specific stockholder approvals required pursuant to the terms of its merger agreement with Seelos Therapeutics, Inc. and the related securities purchase agreement with selected investors.  T... 
12/10/18Apricus Biosciences Reminds Shareholders to Vote Before the Special Meeting on December 14, 2018
Seeking Shareholder Approval for Proposed Merger with Seelos Therapeutics, Inc. SAN DIEGO, Dec. 10, 2018 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq: APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, reminds shareholders to vote by proxy before the upcoming special stockholders meeting on December 14, 2018.  Apricus is holding a special meeting of stockholders in order to obtain the stockholder approvals required pursuant to the terms o... 
Event Calendarmore >
March 2019?
Calendar Help
This calendar contains six months of past and future company related information, which may include press releases, SEC filings, calendar events and more. Dates containing information are indicated by a colored background. You may hover your mouse over a date that contains an event to reveal the event or events taking place on that day including a link to additional information. This calendar requires JavaScript to be installed and activated on your browser.
Calendar Icon Legend:
Analyst Meeting
Conference
Conference Presentation
Corporate Conference Call
Custom Events
Earnings Conference Call
Earnings Release
Financial Reports
Mergers & Acquisition Announcement
Guidance Announcement
Other Corporate
Sales Call/Presentation
Sales Release
Shareholders Meeting
News Release
SEC Filings
Presentations
52 Week High
Today
SMTWTFS
-5-4-3-2-11
03/01/19
8-K/A
Formats:  Excel HTML Adobe PDF Word
2
345678
03/08/19
424B3
Formats:  Excel HTML Adobe PDF Word
8-K
Formats:  Excel HTML Adobe PDF Word
9
1011
03/11/19
SC 13G
Formats:  Excel HTML Adobe PDF Word
1213141516
1718192021
03/21/19
4
Formats:  HTML Adobe PDF Word
4
Formats:  HTML Adobe PDF Word
4
Formats:  HTML Adobe PDF Word
4
Formats:  Excel HTML Adobe PDF Word
2223
24252627282930
31515253545556
Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever Apricus Biosciences, Inc. posts new information to the site. Just enter your e-mail address and click Submit.